Shares of AVEO Pharmaceuticals (AVEO) have gained 9.1% over the past four weeks to close the last trading session at $7.66, but there could still be a solid upside left in the stock if short-term ...
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big ...
Shares of two Massachusetts biotechs, Tetraphase Pharmaceuticals Inc. and Aveo Pharmaceuticals Inc., surged in Thursday trading, far outpacing an impressive across-the-board stock market rally.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback